Pledger v. Janssen

February 2015

Result: Jury Award of $2.5 Million

The Pledger case was the first Risperdal case to go to trial following the $2.2 billion settlement Johnson & Johnson reached with the Justice Department in 2013 for improperly marketing Risperdal to children (and older adults and people with developmental disabilities). A jury found the Johnson & Johnson was “negligent by failing to provide an adequate warning” to the prescribing doctor, and they found that defendants’ “negligent failure to provide an adequate warning was a cause of Austin Pledger’s gynecomastia.” The jury awarded the family $2.5 million.

Public Records:




Cirba v. Janssen

March 2015

Result: Jury finds negligence but not causation

In the second Risperdal trial, the jury reached a split decision. While the jury found the J&J did “negligently fail to adequately warn physicians/health care providers of the extent of the risk of Gynecomastia stemming from the use of Risperdal,” they did not find defendants’ “negligence a substantial factor in bringing about” the plaintiff’s gynecomastia. As a result, no damages were awarded.

Public Records:


Press Reports

PA Superior Court Reverses Risperdal Defense Verdict as Court Strikes Janssen Pharmaceuticals Only Favorable Jury Verdict | MassTortNexus.com | November 17, 2017

J&J's Janssen scores partial victory in second Risperdal trial | Reuters.com | March 20, 2015

Murray v. Janssen

November 2015

Result: Jury Award of $1.75 million

The jury found that Johnson & Johnson did “negligently fail to adequately warn physicians/health care providers of the extent of the risk of Gynecomastia stemming from the use of Risperdal.” The jury also decided that Johnson & Johnson’s negligence was “a substantial factor in bringing about” the plaintiff’s gynecomastia, and they awarded $1.75 million. Because Murray was from Maryland, judge Victor J. DiNubile, Jr. applied a Maryland law that places a cap on “noneconomic damages” available to a plaintiff in a personal injury case, and he entered a reduced judgement of $680,000. The 18 page opinion, however, reinforced many of the plaintiff’s arguments relating to defendants’ negligence and plaintiff’s claim of causation. The Plaintiffs have appealed the application of the damage cap reduction.

Public Records:







Press Reports:

First Two Risperdal Cases Set for Trial on Punitive Damages | Law.com | September 18, 2018

Pa. Appeals Court Sends Back Risperdal Case for Look at Punitive Damages | Law.com | February 21, 2018

J&J Hit With $1.75M Verdict In 4th Philly Risperdal Case | Law360.com | November 9, 2015

Stange v. Janssen

December 2015

Result: Jury Award of $500,000

The plaintiff had breast surgery to correct his gynecomastia. The jury found that defendants were “negligent by failing to provide an adequate warning” to the plaintiff’s doctor and that defendants’ negligence was a cause of his gynecomastia. The jury awarded $500,000.

Public Records:





Press Reports

First Two Risperdal Cases Set for Trial on Punitive Damages | Law.com | September 18, 2018

Pa. Court Won't Rethink Axing Bar On Risperdal Punitives | Law360.com | March 23, 2018

Game Changer Ruling For Risperdal Plaintiffs In Pennsylvania | LawyersAndSettlements.com | January 12, 2018

Court Opens Up Punitive Damages for Boy Who Grew Breasts | CourtHouseNews.com | January 11, 2018

Man who grew breasts after taking medication gets shot at increasing $500K damage award | pennlive.com | January 9, 2018

J&J Found LIable In 3rd Risperdal Breast-Growth Case | Law360.com | December 11, 2015

Yount v. Janssen

October 2016

Result: $76.6 million Judgment

In addition to answering questions about negligence and causation, the jury in the Yount case was asked if defendants did “intentionally falsify, destroy or conceal records containing material evidence in this case?” The jury answered “yes,” and awarded the plaintiff $70 million. Later, Judge Paula A. Patrick issued a judgment order adding $6.66 million in delay damages.

Public Records:





Press Reports:

Judge Urges Pa. Superior Court to Affirm $70M Risperdal Verdict | law.com | June 22, 2018

Judge Tacks $6M In Delay Damages To $70M Risperdal Award | Law360.com | August 12, 2016

Johnson & Johnson Hit With $70M Risperdal Verdict | bna.com | July 6, 2016

J&J must pay $70 million to male teen who took Risperdal and developed large breasts | statnews.com | July 5, 2016

J&J's Janssen hit with $70 million verdict in Risperdal trial | Reuters | July 1, 2016

C.W. v. Janssen

October 2016

Result: Summary Judgement from Arnold L. New

Judge Arnold L. New granted defendant’s Motion for Summary Judgement on the basis that the plaintiff’s doctor might still have prescribed Risperdal if he had been given a proper warning. The Plaintiff is appealing.

Public Records:



Moroni v. Janssen

December 2016

Result: Dismissed by Judge Sean F. Kennedy

11 days into trial, Judge Sean F. Kennedy issued a bench order dismissing the case on grounds that he did not believe that plaintiff’s expert witness testimony met certain requirements of Texas law in pharmaceutical cases. The same expert had testified in previous trials that went to verdict. Plaintiff has appealed the decision.

Public Records:



Press Reports

Sixth Risperdal Case Head In Philly Dismissed By Judge | PennRecord.com | December 22, 2016

New Judge Knocks Out Plaintiff's Expert, Abruptly Dismisses Risperdal Case | Mass Tor Nexus | December, 14 2016

Philly Judge Junks J&J Risperdal Case Midtrial | Law360.com | December 13, 2016

P.D. v. Janssen

February 2017

Result: Summary Judgement from Judge Arnold L. New

In a one-paragraph order, Judge Arnold L. New, granted defendant’s Motion for Summary Judgement on the basis that the plaintiff’s doctor might still have prescribed Risperdal if he had been given a proper warning. The Plaintiff is appealing.

Public Records:


Press Reports:

Recent Risperdal Lawsuit Tossed, Plaintiffs Plan to Appeal | LawyersAndSettlements.com | March 20, 2017

Judge Hands Win To J&J In Latest Philly Risperdal Case | Law360.com | March 3, 2017

Hibbs v. Janssen

April 2017

Result: Compulsory Nonsuit granted by Judge Kenneth Powell

Midtrial, Judge Kenneth Powell issued a one-page order granting the defendants’ Motion for Nonsuit. Judge Powell's order did not provide any reasoning for his decision. He had declared an earlier mistrial when a juror fell ill and the Plaintiff's medical expert rendered air to the ill juror. Plaintiff's lawyers have appealed the decision.

Public Records:


Press Reports:

Pa. Judge Urged to Rethink Midtrial Toss of Risperdal Suit | Law360.com | May 3, 2017

Janssen Pharmaceuticals Granted Nonsuit Motion In Latest Philadelphia Risperdal Lawsuit | pennrecord.com | April 24, 2017

Pa. Judge Axes Latest Risperdal Breast-Growth Case Mid-Trial | Law360.com | April 17, 2017

Latest Risperdal Trial Restarted After Health Emergency Resulted In A Mistrial | lawyersandsetlements.com | April 7, 2017

New Philly Jury Begins 7th Risperdal Trial | law360.com | April 3, 2017